KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity
- 14 October 2021
- journal article
- research article
- Published by Elsevier BV in Microbial Pathogenesis
- Vol. 161 (Pt A), 105243
- https://doi.org/10.1016/j.micpath.2021.105243
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral RevascularizationPLOS ONE, 2012
- In vitro transcriptomic prediction of hepatotoxicity for early drug discoveryJournal of Theoretical Biology, 2011
- Association between kinase insert domain-containing receptor gene polymorphism and haplotypes and ischemic strokeJournal of the Neurological Sciences, 2011
- Evaluation of the effects of a VEGFR-2 inhibitor compound on alanine aminotransferase gene expression and enzymatic activity in the rat liverComparative Hepatology, 2011
- Hypoxia‐inducible factor‐dependent production of profibrotic mediators by hypoxic hepatocytesLiver International, 2009
- The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancerBMC Cancer, 2009
- Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Toxicities Associated with Dual Nucleoside Reverse‐Transcriptase Inhibitor Regimens in HIV‐Infected ChildrenThe Journal of Infectious Diseases, 2008
- Alcohol Consumption and HIV Disease ProgressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Association of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Gene Polymorphisms with Coronary Artery Lesions of Kawasaki DiseasePediatric Research, 2004